Explore our corporate updates and press releases below. For the latest news, follow us on LinkedIn.
To learn more about our company, visit our Corporate Overview page. To see our progress toward new answers and disease-centric therapies, visit our Pipeline page or review recent articles and studies on our Publications page.
|04/05/2021||Ichnos Sciences Appoints Cyril Konto, M.D., Chief Medical Officer||Press Release|
|03/02/2021||Ichnos Sciences Appoints Michael D. Price as CFO||Press Release|
|01/14/2021||Ichnos Sciences to Present at 39th Annual J.P. Morgan Healthcare Conference||Press Release|
|09/22/2020||Ichnos Sciences Adds Lawrence Olanoff, M.D., Ph.D., to Board of Directors||Press Release|
|05/05/2020||Ichnos Sciences appoints David Lubner to Board of Directors||Press Release|
|02/05/2020||Ichnos expands leadership team with appointment of Gabriela Gruia, M.D. as Chief Development Officer||Press Release|
|12/04/2019||Ichnos Sciences expands leadership team with key appointments||Press Release|
|11/24/2019||Ichnos Sciences strengthens board with addition of Marcela Maus, MD, PHD||Press Release|
|11/04/2019||Ichnos Sciences announces completion of enrollment of phase 2B trials for two investigational therapies – ISB 830 and ISC 27864||Press Release|
|10/15/2019||Ichnos Sciences launches as new, independent, leading-edge biotech Dedicated to Outpacing Disease||Press Release|